Previous studies which consisted of moderate and severe COVID-19 patients observed decreased frequencies of total CD127+ ILC (3, 13), which was especially pronounced in severe COVID-19 patients and correlated with duration of hospitalization and severity of inflammation (13, 14). This evidence concerns the gene IL7R and COVID-19.